We found no evidence for the association of FANCG GPVs and ER‐negative BC identified in 4/17 (23.5%) carriers and 2321/8383 (27.7%) all BC patients with known ER status, suggested by Nierenberg et al. This evidence concerns the gene FANCG and breast cancer.